Does RISDIPLAM Cause Product packaging quantity issue? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Product packaging quantity issue have been filed in association with RISDIPLAM (EVRYSDI). This represents 0.3% of all adverse event reports for RISDIPLAM.
10
Reports of Product packaging quantity issue with RISDIPLAM
0.3%
of all RISDIPLAM reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product packaging quantity issue From RISDIPLAM?
Of the 10 reports.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISDIPLAM. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does RISDIPLAM Cause?
No adverse event (324)
Diarrhoea (280)
Asthenia (209)
Pneumonia (182)
Death (165)
Pyrexia (152)
Fatigue (145)
Muscular weakness (125)
Vomiting (121)
Drug ineffective (115)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which RISDIPLAM Alternatives Have Lower Product packaging quantity issue Risk?
RISDIPLAM vs RISEDRONATE
RISDIPLAM vs RISEDRONIC ACID
RISDIPLAM vs RISPERDAL
RISDIPLAM vs RISPERDAL CONSTA
RISDIPLAM vs RISPERIDONE